166 related articles for article (PubMed ID: 26857460)
21. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
[TBL] [Abstract][Full Text] [Related]
22. PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.
Guadagno E; Vitiello M; Francesca P; Calì G; Caponnetto F; Cesselli D; Camorani S; Borrelli G; Califano M; Cappabianca P; Arra C; Crescenzi E; Cerchia L; De Caro MLDB; Fedele M
Oncotarget; 2017 Aug; 8(35):59282-59300. PubMed ID: 28938636
[TBL] [Abstract][Full Text] [Related]
23. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma.
Bar EE; Chaudhry A; Lin A; Fan X; Schreck K; Matsui W; Piccirillo S; Vescovi AL; DiMeco F; Olivi A; Eberhart CG
Stem Cells; 2007 Oct; 25(10):2524-33. PubMed ID: 17628016
[TBL] [Abstract][Full Text] [Related]
24. Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.
Liu J; Liu L; Xue Y; Meng F; Li S; Wang P; Liu Y
Biochem Pharmacol; 2014 Jun; 89(4):477-89. PubMed ID: 24792437
[TBL] [Abstract][Full Text] [Related]
25. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
[TBL] [Abstract][Full Text] [Related]
26. IGFBP2 promotes glioma tumor stem cell expansion and survival.
Hsieh D; Hsieh A; Stea B; Ellsworth R
Biochem Biophys Res Commun; 2010 Jun; 397(2):367-72. PubMed ID: 20515648
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma.
Jin Q; Zhang W; Qiu XG; Yan W; You G; Liu YW; Jiang T; Wang L
Chin Med J (Engl); 2011 Sep; 124(17):2584-8. PubMed ID: 22040407
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomic and Proteomic Data Integration and Two-Dimensional Molecular Maps with Regulatory and Functional Linkages: Application to Cell Proliferation and Invasion Networks in Glioblastoma.
Gupta MK; Jayaram S; Reddy DN; Polisetty RV; Sirdeshmukh R
J Proteome Res; 2015 Dec; 14(12):5017-27. PubMed ID: 26464075
[TBL] [Abstract][Full Text] [Related]
29. 1H NMR metabolomics analysis of glioblastoma subtypes: correlation between metabolomics and gene expression characteristics.
Cuperlovic-Culf M; Ferguson D; Culf A; Morin P; Touaibia M
J Biol Chem; 2012 Jun; 287(24):20164-75. PubMed ID: 22528487
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of DLX2 confers a poor prognosis in glioblastoma patients by inducing a proliferative phenotype.
Yan ZH; Bao ZS; Yan W; Liu YW; Zhang CB; Wang HJ; Feng Y; Wang YZ; Zhang W; You G; Zhang QG; Jiang T
Curr Mol Med; 2013 Mar; 13(3):438-45. PubMed ID: 23331016
[TBL] [Abstract][Full Text] [Related]
31. The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells.
Lemarié A; Lubrano V; Delmas C; Lusque A; Cerapio JP; Perrier M; Siegfried A; Arnauduc F; Nicaise Y; Dahan P; Filleron T; Mounier M; Toulas C; Cohen-Jonathan Moyal E
Sci Adv; 2023 Nov; 9(44):eadi0114. PubMed ID: 37922359
[TBL] [Abstract][Full Text] [Related]
32. RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma.
Boyrie S; Delmas C; Lemarié A; Lubrano V; Dahan P; Malric L; Luis J; Gilhodes J; Tosolini M; Mouly L; Lehmann M; Toulas C; Cohen-Jonathan Moyal E; Monferran S
Oncotarget; 2018 Sep; 9(73):33788-33803. PubMed ID: 30333910
[TBL] [Abstract][Full Text] [Related]
33. Proteomic Characterization of Two Extracellular Vesicle Subtypes Isolated from Human Glioblastoma Stem Cell Secretome by Sequential Centrifugal Ultrafiltration.
Di Giuseppe F; Carluccio M; Zuccarini M; Giuliani P; Ricci-Vitiani L; Pallini R; De Sanctis P; Di Pietro R; Ciccarelli R; Angelucci S
Biomedicines; 2021 Feb; 9(2):. PubMed ID: 33546239
[TBL] [Abstract][Full Text] [Related]
34. Sample Level Enrichment Analysis of KEGG Pathways Identifies Clinically Relevant Subtypes of Glioblastoma.
Wanggou S; Feng C; Xie Y; Ye L; Wang F; Li X
J Cancer; 2016; 7(12):1701-1710. PubMed ID: 27698907
[No Abstract] [Full Text] [Related]
35. Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs.
Grande S; Palma A; Ricci-Vitiani L; Luciani AM; Buccarelli M; Biffoni M; Molinari A; Calcabrini A; D'Amore E; Guidoni L; Pallini R; Viti V; Rosi A
Stem Cells Int; 2018; 2018():3292704. PubMed ID: 29531533
[TBL] [Abstract][Full Text] [Related]
36. Corrigendum: Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
Network TC
Nature; 2013 Feb; 494(7438):506. PubMed ID: 23389443
[No Abstract] [Full Text] [Related]
37. [Emphasis on clinical and pathologic characteristics of rare subtypes of glioblastoma].
Yu S
Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):297-300. PubMed ID: 26178208
[No Abstract] [Full Text] [Related]
38. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
Kim SH; Ezhilarasan R; Phillips E; Gallego-Perez D; Sparks A; Taylor D; Ladner K; Furuta T; Sabit H; Chhipa R; Cho JH; Mohyeldin A; Beck S; Kurozumi K; Kuroiwa T; Iwata R; Asai A; Kim J; Sulman EP; Cheng SY; Lee LJ; Nakada M; Guttridge D; DasGupta B; Goidts V; Bhat KP; Nakano I
Cancer Cell; 2016 Feb; 29(2):201-13. PubMed ID: 26859459
[TBL] [Abstract][Full Text] [Related]
39. Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance.
Fidoamore A; Cristiano L; Antonosante A; d'Angelo M; Di Giacomo E; Astarita C; Giordano A; Ippoliti R; Benedetti E; Cimini A
Stem Cells Int; 2016; 2016():6809105. PubMed ID: 26880981
[TBL] [Abstract][Full Text] [Related]
40. Use of genetically engineered stem cells for glioma therapy.
Namba H; Kawaji H; Yamasaki T
Oncol Lett; 2016 Jan; 11(1):9-15. PubMed ID: 26870161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
